Research Grants 804 show all


$44.4M
2016

$40.2M
2017

$42M
2018

$43.1M
2019

$29.7M
2020

Patents 32show all

  • 14
    A61K - Preparations for medical, dental, or toilet purposes
  • 13
    G01N - Investigating or analysing materials by determining their chemical or physical properties
  • 5
    C07K - Peptides
  • 5
    C12N - Microorganisms or enzymes
  • 4
    C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms
  • 1
    A01K - Animal husbandry
  • 1
    A61B - Diagnosis
  • 1
    A61N - Electrotherapy

Publications 989 show all

  • 93
    CD4-Positive T-Lymphocytes/immunology
  • 61
    Diabetes Mellitus, Type 1/immunology
  • 55
    T-Lymphocytes, Regulatory/immunology
  • 42
    T-Lymphocytes/immunology
  • 38
    Epitopes, T-Lymphocyte/immunology
  • 26
    T-Lymphocyte Subsets/immunology
  • 24
    Diabetes Mellitus, Type 1/genetics
  • 20
    Diabetes Mellitus, Type 1/drug therapy
  • 18
    Cytokines/immunology
  • 17
    Allergens/immunology

Clinical Trials 48show all

12N/A11Phase 25Phase 13Early Phase 13Phase 33Phase 42Phase 1/Phase 21Other

Contact Information

Virginia Mason. 1201 Ninth Avenue
Seattle, WA 98101-2795
United States